| Dr Marwan Samir Ghabril, MD | |
|
550 University Blvd, Uh 4100, Indianapolis, IN 46202-5149 | |
| (317) 944-8660 | |
| Not Available |
| Full Name | Dr Marwan Samir Ghabril |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 550 University Blvd, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366431231 | NPI | - | NPPES |
| 200906740 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01064994A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Indiana University Health Ball Memorial Hospital | Muncie, IN | Hospital |
| Eskenazi Health | Indianapolis, IN | Hospital |
| Union Hospital Inc | Terre haute, IN | Hospital |
| Iu Health West Hospital | Avon, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Diagnostic Associates Inc | 3375446347 | 279 |
News Archive
Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels.
A new University of Michigan study that used stronger statistical controls than previous research lends additional support against corporal punishment, saying the effects can be detrimental to children.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
Nu Skin Enterprises, Inc. today announced record first-quarter results, with revenue of $364.1 million, a 23 percent improvement over the prior-year period. Quarterly revenue was positively impacted 8 percent by foreign currency fluctuations.
› Verified 7 days ago
| Entity Name | University Medical Diagnostic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861441537 PECOS PAC ID: 3375446347 Enrollment ID: O20040202000510 |
News Archive
Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels.
A new University of Michigan study that used stronger statistical controls than previous research lends additional support against corporal punishment, saying the effects can be detrimental to children.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
Nu Skin Enterprises, Inc. today announced record first-quarter results, with revenue of $364.1 million, a 23 percent improvement over the prior-year period. Quarterly revenue was positively impacted 8 percent by foreign currency fluctuations.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marwan Samir Ghabril, MD Po Box 44994, Indianapolis, IN 46244-0994 Ph: () - | Dr Marwan Samir Ghabril, MD 550 University Blvd, Uh 4100, Indianapolis, IN 46202-5149 Ph: (317) 944-8660 |
News Archive
Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels.
A new University of Michigan study that used stronger statistical controls than previous research lends additional support against corporal punishment, saying the effects can be detrimental to children.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
Nu Skin Enterprises, Inc. today announced record first-quarter results, with revenue of $364.1 million, a 23 percent improvement over the prior-year period. Quarterly revenue was positively impacted 8 percent by foreign currency fluctuations.
› Verified 7 days ago
Irene A Carrothers, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |